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Efforts in structural biology have targeted the systematic determination of all protein structures through experimental
determination or modeling. In recent years, 3-D electron cryomicroscopy (cryoEM) has assumed an increasingly
important role in determining the structures of these large macromolecular assemblies to intermediate resolutions (6–
10 A˚). While these structures provide a snapshot of the assembly and its components in well-defined functional states,
the resolution limits the ability to build accurate structural models. In contrast, sequence-based modeling techniques
are capable of producing relatively robust structural models for isolated proteins or domains. In this work, we
developed and applied a hybrid modeling approach, utilizing cryoEM density and ab initio modeling to produce a
structural model for the core domain of a herpesvirus structural protein, VP26. Specifically, this method, first tested on
simulated data, utilizes the cryoEM density map as a geometrical constraint in identifying the most native-like models
from a gallery of models generated by ab initio modeling. The resulting model for the core domain of VP26, based on
the 8.5-A˚ resolution herpes simplex virus type 1 (HSV-1) capsid cryoEM structure and mutational data, exhibited a
novel fold. Additionally, the core domain of VP26 appeared to have a complementary interface to the known upper-
domain structure of VP5, its cognate binding partner. While this new model provides for a better understanding of the
assembly and interactions of VP26 in HSV-1, the approach itself may have broader applications in modeling the
components of large macromolecular assemblies.
Citation: Baker ML, Jiang W, Wedemeyer WJ, Rixon FJ, Baker D, et al. (2006) Ab initio modeling of the herpesvirus VP26 core domain assessed by CryoEM density. PLoS
Comput Biol 2(10): e146. DOI: 10.1371/journal.pcbi.0020146
Introduction
Multicomponent macromolecular assemblies contribute to
nearly all essential biological processes, and as such, the
analysis of these assemblies is critical in understanding basic
cell biology and is potentially relevant to treating disease.
Structural biology offers the promise of understanding
biological molecules through the study of their architecture
and shape. Traditionally, such understanding has been
acquired by determining the 3-D structures of individual
proteins or small complexes using X-ray crystallography and
nuclear magnetic resonance spectroscopy. In recent years,
electron cryomicroscopy (cryoEM) has become increasingly
important in determining structures of complex macro-
molecular assemblies, including the ribosome [1], acrosomal
bundle [2], bacterial ﬂagella [3], clathrin [4], and viruses [5].
However, at present, the best cryoEM density maps are still
limited to intermediate resolutions (6–10 A˚), making it a
daunting challenge to resolve high-resolution structural
features. While there are examples of computational tools
for detecting structural features [6–8] and for ﬁtting the
components of an assembly at intermediate resolutions [9–
14], methods are just beginning to emerge for generating
models in the context of cryoEM density maps [15].
Protein Modeling
In many cases, it is not possible to directly solve the
structure of a protein using experimental techniques. For
these proteins, modeling represents the only effective way of
determining the structure. In general, modeling can be
divided into two categories; template modeling (threading,
comparative modeling) and template-free or ab initio
modeling [16]. While the approach of these techniques varies,
the overall concept for both involves applying a variety of
constraints to optimally produce a structural model that is
useful in understanding the overall structural characteristics
of the protein even in the most difﬁcult modeling cases.
As the name suggests, template-based modeling requires a
related structure for the modeling of a target protein
sequence. In these types of modeling cases, it is possible to
generate a set of models based on single, multiple, or even
alternate templates and alignments, from which the best
model in a set is selected through statistical analysis [17].
Recent work has shown that cryoEM density can discriminate
between alternative models [14]. This has led to a sequence
alignment, modeling, and reﬁnement protocol that utilizes
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both cryoEM density and comparative modeling consider-
ations in an iterative comparative modeling procedure [15].
Unlike comparative modeling, ab initio modeling does not
rely on a template structure, rather it focuses on the physics
of protein folding. In general, ab initio methods are restricted
to relatively small proteins and are not as good as models
based on related structural templates. Most ab initio
modeling can be thought of as an optimization problem
attempting to identify the native structure of an individual
protein by ﬁnding the lowest energy model from a large
gallery of possible models. To date, Rosetta [18] has been
shown to be relatively successful in ab initio modeling.
Rosetta is based on a picture of protein folding in which local
sequence segments rapidly alternate between different
possible local structures, and folding occurs when the
conformations and relative orientations of these local seg-
ments combine to form low-energy global structures. The
distribution of conformations sampled by an isolated chain
segment is approximated by the distribution of conforma-
tions adopted by that sequence segment and related sequence
segments in the protein structure database. Nonlocal inter-
actions are optimized by a Monte Carlo search through the
set of conformations that can be built from these fragment
ensembles; resulting structures therefore have low free
energy for local and nonlocal interactions.
Herpes Simplex Virus Type-1
Herpesviridae is a family of large DNA viruses, several of
which infect humans and cause diseases such as chicken pox,
mononucleosis, and facial and genital lesions [19]. Some
members of the family are highly pervasive; herpes simplex
virus type-1 (HSV-1), the prototypical member of the family,
is present in 40%–80% of the worldwide population [20].
One of the largest and most complex human viruses, HSV-1
(;2000 A˚ in diameter) is composed of an outer glycoprotein-
containing envelope surrounding an amorphous protein
layer, the tegument, which in turn surrounds an icosahedral
nucleocapsid containing the linear dsDNA genome [21]. The
HSV-1 capsid is arranged on a T¼ 16 icosahedral lattice and
consists of 150 hexons and 11 pentons connected by 320
heterotrimeric complexes known as triplexes. Both pentons
and hexons are composed of VP5, the major capsid protein
(149 kDa). Present in the hexon subunits but absent from
pentons is another protein, VP26 (12 kDa), which forms a
hexameric ring on the outermost surface of each hexon [22].
The triplexes, containing one copy of VP19C (50 kDa) and
two copies of VP23 (34 kDa), bridge the neighboring hexons
and pentons [23]. These proteins will spontaneously self-
assemble to form capsids in the presence of an internal
scaffolding protein that is lost during DNA packaging [24,25].
CryoEM and structural analysis of the capsid have
produced a structural model for the architecture/topology
of VP5 [26]. The X-ray structure of a bacterially expressed
domain of VP5 comprising residues 451-1054 was localized to
the upper domain of the hexon and penton subunits
extracted from the 8.5-A˚ cryoEM map of the HSV-1 capsid
[27]. Additional structural analysis has resulted in a topo-
logical model for the remaining portion of VP5, revealing a
structural similarity, and possible evolutionary relationship,
to the capsid protein in tailed dsDNA bacteriophages [28].
HSV-1 VP26
While all mammalian and avian herpesviruses encode for a
small capsid protein that binds to the major capsid protein
(VP26 and VP5 in HSV-1, respectively), their sequences
contain only 36% pairwise and less than 10% overall
sequence identity on average ([29] and protein domain family
alignments database (PFAM) alignment of Herpes_UL35).
No deﬁnitive function has been ascribed to HSV-1 VP26 or its
equivalents, although it is believed to be involved in
stabilizing hexons. Additionally, coexpressed VP26, VP5,
and a scaffolding protein have been shown to assemble into
complexes and translocate to the nucleus [30]. Mutants
lacking VP26 grow normally in cell culture but are partially
inhibited for growth in mice [31].
No high-resolution structure exists for VP26 or any of its
equivalents nor are there any homologous structures. In fact,
VP26 may exist in a monomer–dimer equilibrium, complicat-
ing high-resolution structural studies [29]. However, the
combination of the X-ray and cryoEM structures did result
in the localization of the density belonging to VP26 in hexon
subunits [22,27]. As previously stated, VP26, a minor
structural protein, only binds to VP5 in hexons; pentonal
VP5s are instead bound, in the intact virion, to a large
tegument protein, believed to be VP1–3. While structural
analysis of the VP26 cryoEM density revealed no detectable
secondary structure, circular dichroism studies indicated that
bacterially expressed VP26, which had been solubilized with
CHAPS and alterations to the ionic strength, was almost 80%
b-sheet and only 13%–15% a-helical [29]. However, Desai et
al., using sequence-based secondary-structure prediction
techniques, identiﬁed relatively little secondary structure,
except for a helical region between residues 46 and 66 [32].
Therefore, VP26 may undergo dynamic structural changes
between its bound and unbound states.
The difﬁculty in purifying native VP26 makes it difﬁcult to
determine its structure experimentally. As such, we have
developed a hybrid modeling protocol using ab initio models
generated with Rosetta in conjunction with cryoEM density
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Synopsis
Efforts in structural genomics have targeted the systematic
determination of all protein structures primarily using X-ray
crystallography and nuclear magnetic resonance. These initiatives
have typically focused on domains, single-protein and in some cases
small complexes, and as such macromolecular machines are
relatively underrepresented. However, in recent years, electron
cryomicroscopy (cryoEM) has assumed an increasingly important
role in determining the structure of large macromolecular machines
in their biologically active states to intermediate resolutions (5–10
A˚). Concurrently, modeling techniques, such as comparative and ab
initio modeling, have played an increasingly important role in
structure determination of small proteins not amenable to other
structural techniques. In this work, Baker and colleagues have
leveraged ab initio modeling and cryoEM to assess and identify
structural models for the macromolecular components within a
large complex. Specifically, the cryoEM density can be used to select
the most native-like models from a large gallery of potential models.
Applied to the smallest herpesvirus capsid protein, VP26 (12 kDa), it
was possible to determine its core domain structure (residues 42–
105), which helped to elucidate interactions among the structural
protein in the virion. Beyond VP26, these techniques potentially
provide a new pathway for accurate structure determination of
proteins in their biological and functional states.
Modeling HSV-1 VP26
assessment in an effort to improve the accuracy of the
predicted structure of a VP26 core domain and to understand
its interactions with other capsid proteins. In this paper, we
present a VP26 core domain model, as well as an approach
for determining/evaluating optimal structural models with
the constraints imposed by a medium-resolution cryoEM
density map. Such methodology may be generally applicable
in modeling small proteins or domains from other macro-
molecular assemblies imaged by cryoEM.
Results
Hybrid Modeling with Cryo-EM
In this work, we have designed and implemented a protocol
that augments the results from Rosetta ab initio modeling by
using cryoEM density as a means for assessment. This
methodology (described in detail in Materials and Methods)
leverages the medium-resolution density envelope supplied
by the cryoEM density map to provide the overall shape and
density distribution in evaluating models when no structural
homolog is known. In brief, a shape descriptor replaces the
radius of gyration in a standard Rosetta modeling procedure,
and a composite score based on twelve individual scores,
including radius of gyration, is generated for every model.
Once a set of decoys (possible models) has been generated,
the individual models can be compared with a reduced
representation of the cryoEM density map (a set of
representative Ca atoms) using a two-way distance measure,
and ranked. Initial representation and ranking of the models
using a set of discrete points followed by a more exhaustive
density-based search of the top models was used to minimize
the computational time. From this, the most native-like
model(s) can be selected and analyzed.
Validation of a Known Structure, Hepatitis B Core Protein
In developing our hybrid modeling/evaluation protocol,
the hepatitis B virus capsid protein, for which an X-ray crystal
structure is available [33], was used as a test specimen. While
hepatitis B was among the ﬁrst subnanometer-resolution
single-particle cryoEM reconstructions [34,35], the density
maps are not available in the public cryoEM structure
repository at the European Bioinformatics Institute. There-
fore, a simulated density map of the hepatitis B capsid
protein was generated from the crystal structure at 7.5-A˚
resolution with a sampling size of 2.3 A˚/pixel (Figure 1A),
similar to the authentic cryoEM map. Approximately 10,000
decoys were constructed and evaluated using the density map
to re-rank the decoys scored with the standard Rosetta energy
score (see Materials and Methods).
Individual models were ranked based on their similarity
score to the reduced representation density map, where lower
scores correspond to models that better agree with the
reduced representation density and thus better agree with the
native structure (see Materials and Methods). Model 6072 had
the lowest two-way similarity score (3.25 A˚) and correlated
well (0.74) with the simulated density (Figure 1A–1C). The
next best models, also based on the two-way similarity score,
had larger values at about 3.4 A˚. In analyzing the decoys
without the aid of the simulated cryoEM density (based on the
composite Rosetta score), model 4582 was identiﬁed as the top
candidate model (Figure S1). However, when ﬁt to the
density, the correlation score of this model was signiﬁcantly
worse, 0.59, and had a two-way similarity score of greater than
5.0 A˚.
Since the X-ray structure for the hepatitis B capsid protein
is known (1QGT), additional model assessment could be
accomplished through direct comparison of the X-ray
structure to the individual models. Visual comparison of
model 6072 reveals a striking structural similarity to the
corresponding X-ray structure (Figure 1D), while model 4582
appeared to have little structural similarity. The RMS
deviation between model 6072 and the X-ray structure was
6.22 A˚ for all 142 amino acids, while model 4582 had a RMS
deviation of 9.15 A˚ when calculated with Matchmaker utility
in University of California San Francisco’s Chimera software
[36]. Moreover, model 6072 had an RMS deviation of only 3.0
A˚ for the best 83 consecutive amino acids based on the LGA
evaluation method [37]. Further comparison of all ;10,000
decoys with respect to the X-ray crystal structure in fact
reveals that model 6072 generated by Rosetta was the most
native-like model, as it had the lowest overall RMS deviation
from the X-ray structure of any decoy. Based on this
simulation, cryoEM density appears to be a valuable metric
in the assessment of ab initio models.
Dali [38] and DejaVu [39], structure comparison tools, were
used to further validate quantitatively the quality of the
models. Individual models were used as probes in querying
Figure 1. Modeling the Hepatitis B Capsid Protein
The simulated density map of the hepatitis B virus capsid protein at 7.5-A˚ resolution is shown in grey (A). A reduced representation of the density map
(orange spheres) is shown superimposed on the hepatitis B capsid protein density (B). The best decoy (6072) based on the described hybrid modeling
protocol is shown superimposed on the simulated density (C). A comparison of the model structure (green-orange) and actual hepatitis B Virus capsid
protein (red) is shown in (D).
DOI: 10.1371/journal.pcbi.0020146.g001
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the Protein Data Bank (PDB) for the most similar structure,
which included the hepatitis B structure. Both Dali (5.9 A˚ for
129 amino acids) and DejaVu (2.1 A˚ for 70 amino acids)
returned 1QGT as the top-scoring structure for model 6072;
however, model 4582 did not return 1QGT as a top structural
homolog. As such, model 6072, selected using the cryoEM
ﬁltering method described (Materials and Methods), was
indeed the most native-like model (i.e., the conformation of
the subunit was the closest to the actual structure), conﬁrm-
ing that this approach has the potential for selecting native-
like structural models using the medium-resolution cryoEM
density map.
HSV-1 Capsid Protein, VP26
As the resolution for the HSV-1 cryoEM map is relatively
low (8.5 A˚) [40], it is not possible to build a high-resolution
structural model solely from the cryoEM density. Addition-
ally, no structural homologues for VP26 are known. Thus, the
aforementioned modeling protocol represents a potential,
and perhaps the best, method for modeling VP26 in the
context of the cryoEM density. A difference map between the
X-ray structure of the upper domain of VP5 [27] and an
averaged hexon subunit from the 8.5 A˚ cryoEM map of HSV-1
capsid (Figure 2A) has already established the region of
density attributable to VP26 (Figure 2B and 2C). The main
body of VP26 density rests on the top outer face of VP5 in the
hexons. Two ‘‘arms’’ protrude from this main VP26 body and
wrap around the sides of VP5. Analysis of a hexon subunit
density map using helixhunter [6] and visual assessment
revealed no deﬁnitive secondary structural elements in
VP26 [26].
Circular dichroism measurements previously estimated
that a bacterially expressed and puriﬁed form of VP26 was
predominantly b-sheet [29]. However, sequence analysis
suggests that VP26 contains considerably less b-sheet content
and possibly several small a-helices, while cryoEM density
analysis revealed no a-helices longer than 2.5 turns or
signiﬁcantly large b-sheets [26,32]. Based on a consensus
multiple secondary-structure prediction, VP26 appears to
have two potentially a-helical regions (Figure 3). The ﬁrst of
these a-helical regions is at the N-terminus (residues 13–31)
that likely contains two small a-helices. The second a-helical
region is located in the middle of the VP26 sequence (residues
42–72) and contains either one large or two smaller a-helices.
Although not as consistently predicted, the C-terminal region
of VP26 may also contain a small a-helix.
Further analysis of the sequence and biochemical data also
begins to provide evidence of the ‘‘gross’’ structure of VP26.
An alignment of all VP26 homologues showed two fairly well-
conserved regions (1–30 and 48–112) separated by a poorly
conserved, gapped region between residues 31 and 47 of
VP26. This organization is supported by previous muta-
genesis that indicates residues 1–50 are not required for
binding to VP5 or native-like function, while several
mutations in the second half of VP26 affect VP269s ability
to bind to VP5 [32].
Modeling a Subdomain of VP26
Based on the aforementioned sequence, VP26 may contain
two discrete structural and/or functional domains, the C-
terminal one being responsible for interactions with VP5.
Only this domain was used in constructing the model for
VP26. Using the secondary-structure prediction as a guide, a
slightly larger region, residues 42–112, was used in the
modeling of this second (core) domain. The size of this
domain corresponds to the approximate mass of the central
VP26 density observed in the cryoEM map (Figure 4A and
4B). Approximately 20,000 decoys of the VP26 core domain
were generated using the Rosetta protocol. These decoys were
screened by both the cryoEM ﬁltering and Rosetta scoring
methods. The top decoys, based on both scores, were selected
and ﬁtted directly to the cryoEM density using foldhunter [6].
Figure 2. Structure of HSV-1 Hexon Subunit
(A) The 8.5-A˚ resolution cryoEM structure of HSV-1 is shown radially colored. A hexon is indicated with an arrow.
(B) The density of a single hexon subunit segmented from the 8.5-A˚ cryoEM map of the HSV-1 capsid is shown.
(C) A top view of the hexon subunit is shown. VP26 shown in blue in (B) and (C) was isolated based on the difference map between the cryoEM density
map of the hexon subunit and the VP5 upper-domain crystal structure.
DOI: 10.1371/journal.pcbi.0020146.g002
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As suggested in the hepatitis B example, the cryoEM density is
capable of discriminating a native-like model from a gallery
of decoys. As such, selection of the ﬁnal VP26 model was
primarily based on the foldhunter cross-correlation score and
the two-way similarity score, as well as being augmented by
visual analysis and correlation with existing sequence/bio-
chemical evidence.
As with the hepatitis B example, decoys selected based
solely on the composite Rosetta energy score had worse two-
way similarity scores than those screened against the cryoEM
map. The top model (3554) based on the composite Rosetta
energy score had a two-way similarity score of 5.16 A˚, close to
the average score (5.19 A˚) for the gallery of decoys.
However, unlike the hepatitis B, there was no singularly
best structure based on the two-way similarity score with the
reduced cryoEM representation (Figure S2 and Table 1).
Rather, 25 decoys had a two-way similarity score better than 4
A˚. All these decoys appeared to share a similar overall
composition, based on visual inspection, although the models
were sufﬁciently different in their structure. Of note, these 25
models, when aligned to each other using Chimera’s Match-
maker, had RMS deviations similar to the resolution of the
experimental cryoEM density map (;8.0 6 1.5 A˚). Of these 25
decoys, the top ten appeared to be relatively self-consistent,
having RMS deviations between 3.77 A˚ and 3.92 A˚ amongst
each other (Figure S3). Additionally, when exhaustively ﬁt to
Figure 3. Secondary-Structure Prediction of VP26
Five secondary-structure prediction algorithms were used to compute the secondary structure (highlighted in green) of VP26. Mutations identified by
Desai et al. [32] are highlighted in red. Helices based on model 8824 are represented by a black bar beneath the primary sequence. The locations on the
VP26 sequence corresponding to the VP1–3 insertions (Figure 6) are labeled with ‘‘v’’ above the primary sequence.
DOI: 10.1371/journal.pcbi.0020146.g003
Figure 4. Modeling VP26
(A) The core domain of the segmented VP26 cryoEM density is colored in blue.
(B) The pseudoatoms (orange spheres) assigned in the density-reduction step are shown superimposed on the cryoEM density of VP26.
(C) The best model of the core domain (residues 42–105) generated by Rosetta and selected using cryoEM density constraints is shown fitted within the
segmented VP26 density. The putative N-terminal and C-terminal density regions are labeled N and C, respectively.
DOI: 10.1371/journal.pcbi.0020146.g004
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the density with foldhunter, the correlation scores of these top
ten models were again very similar, ranging from 0.58 to 0.65,
respectively (Table 1). The remaining 15 models had lower
correlation scores and larger RMS deviations amongst each
other.
To further differentiate among the possible models, the
decoys were analyzed in the context of the VP26 density by
itself and in association with the hexon subunit density from
the original cryoEM map. Of the top models, seven models
had the termini pointing out of the VP26 density, making
them less likely core domain–model candidates. Model 8824
had a highly ranked two-way similarity score and ﬁtting score
(ﬁfth and fourth best, respectively), as well as having ‘‘good’’
orientations for the two VP26 domain termini. As such,
model 8824 (Figure 4C), with a similarity score of 3.88 A˚ and a
correlation score of 0.62, was chosen as the most probable
native-like structure for the core domain of VP26. Again, it is
worth noting that the structural variation of the top 25
models, assessed by calculating the RMS deviation with
respect to model 8824, were on a par with the resolution of
the experimental cryoEM density map.
As with the hepatitis B example, the VP26 core domain
model 8824 was used to search against the PDB for a
homologous structure. No homologous structure was identi-
ﬁed with DejaVu or Dali. As such, the modeled core domain of
VP26 represents a novel fold that contains three short a-
helices, as predicted by secondary-structure prediction
(Figures 3 and 4). These a-helices are small enough that they
would not be identiﬁed through analysis of the 8.5 A˚ cryoEM
capsid density map, which requires a minimum a-helix length
of ;2.5 turns [6]. In model 8824, the N- and C-termini of the
VP26 core domain (residues 42 and 105, respectively) extend
towards the two VP26 ‘‘arms.’’ It was not possible to model
the C-terminal seven amino acids (106–112) by Rosetta, as they
appeared to be disordered. However, these residues can easily
be accommodated by the remaining cryoEM density along the
extended arm. The N-terminal residues (1–41), which were
not modeled, likely extend down the other arm. Density in
this region, which extends below the core domain of VP26,
could account for a large number of these residues. As the
two termini appear to wrap around VP5, it is likely that
interactions between neighboring VP26 molecules occur
exclusively at the N- and C-termini of VP26.
Interactions with VP5
By ﬁtting the VP26 core domain model and the X-ray
structure of the upper domain of VP5 to an HSV-1 hexon
subunit map derived from the cryoEM density, it is possible to
observe potential interactions between the two proteins
(Figure 5A and 5B). The interface between the two proteins
is seen to be dominated by loops, except for one a-helix on
VP5 (832–840, FDRVYATLQ).
Aside from a small clash between a loop in VP26 and an a-
helix in VP5, the surfaces of the proteins appear to have a
relatively complementary interface (Figure S4). Both the
VP26 core domain and the upper domain of VP5 are
dominated by hydrophobic residues at their interface.
However, two small patches of charged residues are located
near each of the VP26 arms (Figure S3). In the ﬁrst of these
VP26 patches, near the N-terminus of the model, residues
R51, E52, R55, and D82 are proximal to a patch of charged
residues on VP5 (R834, D953). The second charged patch on
VP26 (R89, R95, R96, R104, E105), near the C-terminus, also
appears to be proximal to another charged region in VP5
(D775, D833, H899, E903).
Site-directed mutagenesis has previously identiﬁed func-
tionally important residues in VP26 [32]. In particular,
mutations at M78, F79, A80, G93, L94, R95, R96, and T97
eliminated binding of VP26 to VP5 in capsids and mutants in
A58, and L64 reduced binding of VP26 to VP5 in capsids
(Figure 3). Additionally, mutations at F79 and G93 altered the
efﬁciency of translocation to the nucleus, suggesting that
initial interaction of VP26 and VP5 may occur in the
cytoplasm through F79 and G93. It should also be noted that
these residues are the most conserved in all of the members of
the Herpesviridae. Residues 78–80 are absolutely conserved
while residues 93–97 have only one identiﬁed substitution,
lysine replacing arginine at position 96 (from PFAM
Herpes_UL35).
Signiﬁcantly, the regions containing mutations that re-
sulted in elimination of VP26 binding, residues 78–80 and 93–
97, lie at the proposed interface between VP26 and VP5
(Figure 5C and 5D). Residues 78–80 (M78, F79, A80) are
adjacent to two VP5 loops (N341, M342, A872, N873, T874),
while residues 93–97 of VP26 appear close to another VP5
loop (V771, A772, T773). The two mutations at A58 and L64,
which resulted only in decreased binding of VP26 to capsids,
were on an a-helix although not at the VP26/VP5 interface.
Structural Homology: VP26 and the Large Tegument
Protein
As previously mentioned, VP26 binds to VP5 in hexon
subunits but not in penton subunits. However, it has been
shown that a tegument protein, most likely VP1–3, associates
with the penton VP5 subunit at approximately the same
interface that VP26 interacts with hexon VP5 [41]. It has also
been speculated that the differential afﬁnity of VP26 and the
tegument protein for hexon and penton subunits, respec-
tively, is likely based on steric and conformational consid-
erations [27,42]. Locally aligning the primary sequence of
VP26 and VP1–3 revealed a region of similarity (Figure 6A).
Residues 66–96 of VP26, which make up nearly the entire
Table 1. VP26 Decoy Statistics
Model Number Foldhunter Score Ca RMS Deviation Rosetta Score
678 0.66 3.91 15.00
1058 0.63 3.87 24.44
1314 0.61 3.87 28.10
1527 0.58 3.87 27.70
3807 0.60 3.92 32.67
4032 0.59 3.77 14.12
5670 0.62 3.80 17.09
8227 0.61 3.83 25.14
8824 0.62 3.88 19.79
9019 0.64 3.90 12.09
Average Not applicable 5.19 20.76
A list of the top ten models as assessed by the two-way similarity score is shown. The
density fitting score (foldhunter score), the two-way similarity score (Ca RMS deviation),
and composite Rosetta energy score are reported for each model. The average Ca RMS
deviation and Rosetta scores reflect the average scores for the entire population of decoys
(20,000 models). Since only the top decoys were fit to the density, a population average
was not calculated.
DOI: 10.1371/journal.pcbi.0020146.t001
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interaction surface with VP5, share 45.2% identity (80.6%
similarity) to residues 1712–1751 of VP1–3. Additionally, the
alignment of all VP26s and a PSI-Blast alignment of VP1–3s
show this region is highly conserved in both proteins. Based
on this alignment, there appears to be two differences
between the VP26 and VP1–3 sequences: a two-residue
insertion between residues 78 and 79 of VP26 and a larger
six-residue insertion between residues 84 and 85 of VP26
(Figures 3 and 6). Hydrophobicity plots of these regions in
VP26 and VP1–3 show almost identical character, differing
only in the gapped regions (Figure 6B). In the context of the
VP26 core domain model, these gaps are located along a
portion of the probable VP26–VP5 interface. Based on this, it
is reasonable to speculate that the local structure for these
regions in VP26 and VP1–3 are similar and interact with VP5
using the same mechanism.
Discussion
Large macromolecular machines are underrepresented in
the PDB, as their size and complexity can make it difﬁcult to
study them structurally [43,44]. Therefore, proteins from
these macromolecular complexes make a relatively small
contribution to our knowledge of fold space. Because of this,
construction of homology models for macromolecular com-
ponents may be based on suboptimal templates or may not be
possible at all. Since ab initio modeling does not require
structural templates, it offers great promise in modeling
components from large macromolecular assemblies. Though
it is potentially feasible to generate models for the compo-
nents/domains of macromolecular assemblies, a lack of
macromolecular assembly structures may bias the structural
models towards those of single, soluble proteins, potentially
ignoring the extensive interactions within a complex. Never-
Figure 5. VP26 Interactions
(A,B) The VP26 core domain model is shown in the context of the VP5 upper-domain X-ray structure (grey) in a top view and a side view, respectively.
The a-helix in VP5 (832–840) that interacts with VP26 is labeled.
(C,D) Mutations (labeled with arrows and highlighted in red on the ribbon diagram) in VP26 (cyan blue) that affect binding to VP5 as described by Desai
et al. [32] are shown in top and side views, respectively.
DOI: 10.1371/journal.pcbi.0020146.g005
PLoS Computational Biology | www.ploscompbiol.org October 2006 | Volume 2 | Issue 10 | e1461319
Modeling HSV-1 VP26
theless, the major challenge in ab initio modeling still lies in
the identiﬁcation of the most probable native-like models
from a large number of potential models.
Currently, there are many methods for assessing models
from a gallery of decoys, with varying degrees of success.
However, most of the metrics to assess the individual decoys
are based on single, soluble, globular proteins. The assess-
ment method used in the work presented here evaluates the
models in the context of a biologically active entity. As such,
the selected model is reﬂective of the protein in a biologically
active conformation, which may be different from a
biochemically isolated state. Our approach is to include the
maximum amount of biological and structural information in
selecting the best decoys in a biological context.
While limited to medium resolutions, cryoEM can capture
the overall structure of a complex and its components in well-
deﬁned chemical or biological states. In this work, we have
utilized this ‘‘low-resolution’’ information to select for the
most probable native-like models from the ensemble of
structures generated during ab initio modeling. By using a
reduced representation density map, we were able to rapidly
evaluate a large number of potential models for further
analysis. In the case of VP26, exhaustive ﬁtting of all 20,000
models to the original cryoEM density map using standard
density matching methods, such as foldhunter [6], would have
taken more than 1,500 cpu hours, while the calculation of the
aforementioned similarity score for the same number of
decoys required less than one hour on a single cpu. Coupled
with the exhaustive correlation-based search of the top
models, the entire method required less than three cpu
hours. In addition to allowing for the rapid evaluation, the
advantages of this approach were illustrated with the
hepatitis B example, where it was possible to identify the
most native-like model from a set of ;10,000 decoys,
something the composite Rosetta energy score was unable to
do.
This work only represents the initial application of cryoEM
to ab initio modeling. It is likely that this and similar methods
will become increasingly valuable as the number of cryoEM
structures and their complexity continue to grow [44,45].
Similar approaches have already been used with comparative
modeling, in which cryoEM density was shown to capture low-
resolution structural features and facilitate model selection
[14,15]. As such, similar techniques may become common-
place in the near future for the evaluation of structures in
macromolecular complexes.
Modeling Limitations and Accuracy
While seemingly producing credible models for VP26 and
the hepatitis B capsid protein, the described hybrid modeling/
assessment method is not without its limitations. At present,
ab initio modeling is generally limited to proteins or domains
of fewer than 300 amino acids. Unfortunately, the use of
cryoEM is only involved in the assessment of decoys and
cannot remove this limitation. Therefore, this type of hybrid
approach is only appropriate for modeling individual
proteins or domains of this size that can be clearly delineated
Figure 6. Common Sequence Motif in VP26 and VP1–3
A sequence alignment of VP26 and VP1–3 is shown in (A). Identical residues are shown in green, while conserved residues are shown in cyan blue. In (B),
the hydropathy profiles of this region from VP26 (red) and VP1–3 (black) are plotted and labeled with respect to the VP26 sequence. The shaded panels
indicate the regions of insertion found in the sequence alignment.
DOI: 10.1371/journal.pcbi.0020146.g006
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from the cryoEM density maps of the macromolecular
complex. This approach is therefore subject to the limitations
imposed by the intrinsic properties of the cryoEM density
map and the ability to deﬁne subunit boundaries within it. If
the resolution and/or quality are insufﬁcient to accurately
identify the boundaries of the individual components,
domains, or structural features in macromolecular com-
plexes, a cryoEM density map will be incapable of accurately
discriminating amongst different decoys. The true power of
the cryoEM density selection is in the intrinsic shape and
density distribution of the protein in question.
As indicated, the resolution and accuracy of the cryoEM
density map is paramount for accurate model selection. In
the hepatitis B example, simulated cryoEM density was used
to select the top model among the gallery of decoys, which
was also the most native-like decoy, when compared with the
X-ray structure, generated by Rosetta. This, of course, is the
ideal situation and will not always be the case. Generally
though, more accurate models are more likely to be selected
by higher-resolution cryoEM density maps. Additional high-
resolution features, such as secondary structure, may also be
used in model selection or may even be incorporated into the
decoy generation phase in Rosetta.
For VP26 from the HSV-1 capsid cryoEM structure, its
resolution (8.5 A˚) essentially limits the accuracy at which the
most native-like model may be selected. The top models,
when aligned to the VP26 core domain density map, possess
RMS deviations close to the resolution of the cryoEM density
map. Thus, the overall ability to identify the most native-like
decoy in VP26 is directly related to the resolution and quality
of the cryoEM density map, and as such the interpretation of
the model should be judged accordingly. By using other
biochemical and genetic information, the combined bio-
informatics would increase the resolving power of this
approach as demonstrated in this study.
While the cryoEM density information should provide a
metric for selecting a protein or domain, it may not be any
more useful than standard shape descriptors such as radius of
gyration for small, globular folds. In the case of compact
globular folds, the cryoEM density may not be descriptive
enough to select the best possible model for the decoys. With
regard to the two structures modeled in this work, the core
domain model of VP26 was considerably more globular and
compact than the hepatitis B capsid structure. This may
account for the different score distributions in these two
cases and the difﬁculty in selecting the VP26 model based
solely on the two-way similarity score. Furthermore, different
secondary-structure composition, speciﬁcally b-sheets which
are only visualized in relatively high-resolution cryoEM
density maps, could also alter the effectiveness of cryoEM
density in assessment of models. Therefore, as with any
modeling technique, scoring metrics should be viewed as
guides in selecting the best model, but visual interrogation of
the models and correlation with biochemical data is
necessarily the best judge of model accuracy.
Not to be overlooked in evaluating models in the context of
the density is the ability to accurately localize coordinate data
to the density map. Traditionally, ﬁtting techniques, such as
foldhunter [6], are based on exhaustive correlation-based
techniques, which are extremely sensitive but fairly slow. In
this work, we used a reduced representation of the cryoEM
density map, a set of pseudo-Ca atoms, to improve the
computational efﬁciency of decoy evaluation. While this type
of representation allows for a rapid screening of decoys, it
does not replace the sensitivity of an exhaustive correlation-
based ﬁtting technique. This evaluation merely provides an
initial ranking to reduce the number of potential decoys for
further evaluation. Differences in different data-reduction
algorithms (K-means, vector quantization, etc.) will thus not
likely affect the overall outcome of model evaluation. In this
work, we observed comparable placement of pseudoatoms
irrespective of the method used in discritization of the
hepatitis B density map (Figure S1). While the two-way score
varied slightly with the discritization method, the difference
was negligible and did not affect the relative rankings of the
individual models.
VP26 Structure
At present, no structure for VP26, its herpesvirus ana-
logues, or a structural homolog is known. In fact, previous
biochemical work has suggested that HSV-1 VP26 is not very
soluble and exists in a monomer–dimer equilibrium [29].
Structural studies have alternatively hypothesized that VP26
forms hexamers during viral assembly, which could account
for VP269s preference for hexons [22]. It has also been
reported that VP26 must be associated with VP5 to enter the
nucleus, where viral capsid assembly occurs [30]. As such,
soluble, unbound VP26 may in fact be in a different
conformation than VP5-associated VP26. Differences be-
tween circular dichroism measurements of CHAPS solubi-
lized, bacterially expressed VP26, and the sequence and
structural observations may indicate such conformational
variability. Thus, our hybrid modeling approach, which
leverages cryoEM density, may represent the best and at
present possibly the only feasible way to determine a
structural model of HSV-1 VP26 bound to the virus capsid.
In the modeling of VP26, the ﬁrst 41 amino acids were
excluded, as this likely represents a discrete domain. This
portion of the protein had previously been shown to be
nonessential for the interaction with VP5 [32]. Furthermore,
the cryoEM density of VP26 appears to indicate the presence
of a globular domain with one small and one large arm
extending away from the main density. The model of the
VP26 core domain appears to ﬁt well into the main density,
with the two termini pointing towards the individual arms.
The arm, which was assigned to the N-terminus, is relatively
large and can probably be considered as an independent
domain. While this N-terminal density is substantial and can
accommodate most of the ﬁrst 41 amino acids, it is possible
that portions of N-terminus may extend towards the
neighboring VP26 subunit, and our segmentation of a single
VP26 subunit may not be entirely accurate due to the cryoEM
map resolution. This region of density therefore may not fully
reﬂect the entire N-terminus of VP26; however, its implica-
tion in modeling the VP26 core domain is negligible.
Since no other structural data is available for VP26 or
related structures, mutational and structural information can
be used to validate the model. It appears that the core domain
model of VP26 is consistent with the mutational data, since
mutants that abolish VP269s ability to bind to VP5 are placed
at the interface of these two proteins. However, two
mutations (amino acids 58 and 64) that reduce the afﬁnity
of VP26 for VP5 are found in one of the a-helices that form
the outer surface of VP26. Since these mutations are in an a-
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helix, it is possible that mutations at these residues affect the
afﬁnity of VP26 for VP5 by altering the overall VP26
structure.
Molecular Interactions
Structurally, the VP26 core domain model appears to ﬁt
well within the cryoEM density while allowing for the
accommodation of the remaining unmodeled residues. More-
over, the predicted interacting surface of VP26 appears
consistent with what is known about the VP5 interface region.
While the model itself was selected using the cryoEM density,
VP26 was modeled as an independent structural unit. As such,
no bias towards the VP5 interface was enforced. The fact that
the predominantly hydrophobic regions and charged regions
of VP26 and VP5 appear to be complementary further
enforces the plausibility of the model. This is further
augmented by the relative agreement of the mutational data
for VP26. The ﬁtting to the cryoEM map produced only one
slight clash between the VP26 core domain model and the
VP5 upper-domain structure. This clash could reﬂect the
potential for structural variation when VP26 and VP5
interact or could simply be an artifact due to the relatively
low resolution of the cryoEM density map. Furthermore, this
region of VP26 is in a loop, for which model accuracy is likely
to be signiﬁcantly worse than in regions of a-helices or b-
sheets. Regardless, this small clash is likely to be relatively
insigniﬁcant in terms of the overall structure and function of
VP26.
While binding of VP26 to VP5 is speciﬁc to hexons, the
equivalent VP5 interface in pentons is occupied by a
tegument protein (thought to be VP1–3) [22,29,41]. The
different binding speciﬁcities probably reﬂect the varying
structures and spatial arrangements of the VP5 subunits in
hexons and pentons, respectively [26,27]. However, of interest
in the context of the work described here is the similarity in
the footprints occupied by VP26 and VP1–3 on the VP5
subunits. Sequence analysis reveals that the essential binding
region in VP26 shares a high degree of similarity to a short
sequence in VP1–3. The high sequence relatedness and
similar hydrophobicity proﬁles suggest that the local struc-
ture of this portion of VP1–3 probably resembles that of
VP26. If this region of VP1–3 is involved in binding to VP5, it
might be expected to create an equivalent interface to that
seen with VP26. Local differences due to imperfect con-
servation and the inﬂuence of steric considerations and
oligomeric states of VP5 could then account for the differ-
ential binding to hexons and pentons through a similar
interaction interface.
Conclusion
While the results described here represent only a ﬁrst
attempt to model the core domain of VP26, they nevertheless
provide useful insights into the probable organization of
VP26 and its interactions with VP5. Importantly, this model
provides the ﬁrst evidence to our knowledge of VP26
structure from which biological and additional structural
experiments could be carried out to further conﬁrm the
model and the proposed mechanism for interaction. More-
over, the results presented here, in combination with similar
work in comparative modeling [14,15], illustrate the potential
efﬁcacy and credibility of hybrid modeling approaches. Of
particular note is that by using cryoEM density, along with
biochemical and sequence data, it is possible to produce
models in the context of the biologically relevant macro-
molecular assemblies. With the ever-growing availability of
cryoEM density maps, hybrid methods such as this will likely
become increasingly important tools in deciphering macro-
molecular structure and function.
Materials and Methods
Density representation. To efﬁciently integrate cryoEM density
into the modeling protocol, we adopted a reduced representation
based on the density map to faithfully characterize the density
distribution. This representation allows for the rapid comparison of a
large number of models that will be generated during the model-
building process. A similar reduced-density representation strategy
has been previously used in the ﬁtting of coordinate data to cryoEM
density maps [10] and normal mode computations in cryoEM density
maps [46]. Essentially, a deﬁned number of points (pseudoatoms) are
assigned within the density map to faithfully approximate the density
distribution. Assignment of these points can be done using a variety
of algorithms including vector quantization, K-means clustering, or
direct, threshold-based techniques. For the purposes of this work,
pseudoatom assignment was done using K-means clustering in EMAN
[47], although other methods from Situs [10] and EMAN produced
similar results in representing a cryoEM density map accurately at a
given density threshold. In each of these approaches, the pseudoatom
corresponds to a unique density segment, which may not represent a
single, discrete amino acid at the current resolutions obtained by
cryoEM. Only the number of amino acids, corresponding to the
number of pseudoatoms and a density threshold that approximates
the mass of the protein in question, was used in the generation of the
pseudoatoms from segment3d in EMAN [47].
The reduced-density representation corresponds to the density
map ‘‘constraints’’ during the alignment and evaluation of the
predicted decoys (alternative models). In this application, the points
from the reduced representation are conceptually regarded as
pseudo-Ca atoms but without identity, i.e., the amino acid type and
position in the sequence. Figures 1B and 4B depict the pseudoatom
representations in the hepatitis B capsid protein and the VP26 core
domain, respectively.
Density-based model assessment in ab initio structure prediction.
In typical Rosetta predictions, large numbers of decoys are generated
and ranked based on a variety of scoring functions, with varying
degrees of success [48]. Here, the cryoEM density map is used as a new
type of scoring function, based on the overall density shape. The
standard Rosetta composite score consists of 12 independent scores,
including the radius of gyration which preferentially selects more
compact models. In this work, we attempt to improve the score
represented by radius of gyration with a more targeted shape-
matching score by comparing the models with the medium-resolution
cryoEM density map. To rank decoys using the cryoEM density map, a
three-step process was performed:
Rigid body alignment of decoys to the density map. Ellipsoid ﬁtting [6] was
used to align decoys to the reduced-density representation. The
rotation matrix between the principal axes of the ellipsoids was
calculated using a closed-form formula. The decoy coordinates were
transformed to match the density map.
Calculating a similarity score. A score was computed based on the sum
of the distances of every Ca atom to the closest point in the reduced-
representation density map after alignment (step number 1). Addi-
tionally, the distances from every point in the reduced representation
density map to its closest Ca atom in the decoy was calculated and
summed. This two-way distance measure, the average of the two
distance measures, is used to assess map/decoy agreement and
prevent abnormally compact decoys from incorrectly scoring well.
Rank. The scores of all the decoys from step number 2 were ranked.
The top decoys, which have the smallest similarity scores, were chosen
as the most favorable models for further investigation. Further
density-based ﬁtting of the top models to the original cryoEM density
was performed using foldhunter.
Validation with hepatitis B. A single subunit of hepatitis B capsid
protein (142 amino acids) was blurred to produce a 7.5-A˚ resolution
density map using the pdb2mrc program in EMAN [47]. The density
map was then quantized using 142 pseudoatoms using k-means
clustering in the EMAN program segment3d.
The sequence of this protein was subjected to Rosetta prediction,
for which 10,000 backbone-only decoys were generated. Decoys were
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scored using the above-described two-way density-similarity metric.
Comparison of the best model and the native structure was done
using the LGA evaluation method [37], Dali [38], and DejaVu [39].
VP26 density segmentation. VP26 was segmented by ﬁtting the VP5
upper-domain structure to a single hexon subunit from the 8.5-A˚
resolution HSV-1 structure as described previously [27]. Essentially, a
mask can be created from the blurred VP5 density and applied to the
hexon subunit. The remaining density at the outermost portion of
the hexon subunit was designated as VP26.
Sequence analysis. The sequences for VP26 and VP1–3 were
obtained from Swissprot. The sequence alignment of known VP26
homologues in Herpesviridae was obtained from PFAM [49], while the
sequence alignment of VP1–3 was generated using Psi-Blast [50].
Local alignment of VP26 with VP1–3 was done using LALIGN [51].
Hydrophobicity plots were generated based on the Kyte and Doolittle
option with a three amino acid–window size in the ProtScale program
available from http://www.expasy.ch. Secondary-structure prediction
was done online using JPRED [52], Psipred [53], Predator [54], PhD [55],
and SSPRO [56].
Modeling a subdomain of VP26. Based on the aforementioned
sequence analysis and mutational data [32], the VP26 primary
sequence was divided into two domains; residues 1–41 and 42–112.
The second, larger domain (core) was assumed to comprise the
relatively globular domain of the VP26 density. Seventy pseudoatoms,
corresponding to the number of amino acids to be modeled, were
generated using the segment3d program in EMAN.
Twenty thousand decoys were generated for the VP26 core domain
(residues 42–112) using the Rosetta prediction method. All models
were then scored using both the standard composite Rosetta energy
score and the two-way similarity score. Of these models, the top
models based on the Rosetta score and the two-way similarity score
metric, which had better than a 4-A˚ similarity score with the VP26
pseudoatoms, were ﬁt to the VP26 cryoEM density using foldhunter [6].
The foldhunter score, similarity score, Rosetta score clustering, and
visual analysis were then used concurrently to identify the best model.
Supporting Information
Figure S1. Modeling Hepatitis B
The density map for the simulated hepatitis B capsid protein is shown
superimposed on the pseudoatoms (orange), calculated using (A)
vector quantization and (B) K-means. The X-ray structure of the
hepatitis B virus capsid protein is shown as a series of Ca atoms (C),
rainbow-colored blue (N-terminus) through red (C-terminus), and as
a full-ribbon model (D). The top model selected using cryoEM density
is shown in (E), while the model with the best Rosetta score is shown in
(F).
Found at DOI: 10.1371/journal.pcbi.0020146.sg001 (4.6 MB PDF).
Figure S2. Plot of the Two-Way Similarity Score for the VP26 Core
Domain Decoys
The scores for all decoys having a two-way similarity score less than 8
A˚ RMSD with the reduced representation density have been plotted.
The average of these ;12,000 decoys was 5.19 A˚ (green line). A
zoomed in view (red box) of the top 250 decoy scores is shown in the
subplot.
Found at DOI: 10.1371/journal.pcbi.0020146.sg002 (1.3 MB PDF).
Figure S3. VP26 Core Domain Decoys
A gallery of the top ten decoys using the two-way similarity score is
shown. Additionally, model 3554, which has the best Rosetta energy
score, is shown in the upper right corner of the gallery. The best
model (8824) is superimposed on the pseudoatoms constructed from
the VP26 density map. All models are shown as ﬁt to the density using
foldhunter and viewed as in Figure 4.
Found at DOI: 10.1371/journal.pcbi.0020146.sg003 (6.5 MB PDF).
Figure S4. Capsid Protein Interactions
The interactions of VP26 and VP5 are shown in relation to
electrostatic potential (row 1) and hydrophobicity (row 2). Positive
residues are colored in blue, negative residues are colored in red, and
hydrophobic residues are shown in salmon.
Found at DOI: 10.1371/journal.pcbi.0020146.sg004 (5.2 MB PDF).
Accession Numbers
For materials mentioned in this paper, the accession numbers from
the Protein Data Bank (PDB) (http://www.rcsb.org/pdb) are: for
hepatitis B virus capsid protein (X-ray crystal structure) (1QGT);
and for VP5 upper-domain crystal structure (1NO7). The accession
number from PFAM (http://pfam.wustl.edu/) is for VP26 homologues
(Herpes_UL35). Accession numbers from Swiss Prot (http://
swissprot.org) are: VP26 (P10219) and VP1–3 (P10220).
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